Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada; Department of Clinical Biochemistry, University Health Network, Toronto, Canada.
Mol Cell Proteomics. 2021;20:100155. doi: 10.1016/j.mcpro.2021.100155. Epub 2021 Sep 28.
Probing the human proteome in tissues and biofluids such as plasma is attractive for biomarker and drug target discovery. Recent breakthroughs in multiplex, antibody-based, proteomics technologies now enable the simultaneous quantification of thousands of proteins at as low as sub fg/ml concentrations with remarkable dynamic ranges of up to 10-log. We herein provide a comprehensive guide to the methodologies, performance, technical comparisons, advantages, and disadvantages of established and emerging technologies for the multiplexed ultrasensitive measurement of proteins. Gaining holistic knowledge on these innovations is crucial for choosing the right multiplexed proteomics tool for applications at hand to critically complement traditional proteomics methods. This can bring researchers closer than ever before to elucidating the intricate inner workings and cross talk that spans multitude of proteins in disease mechanisms.
在组织和生物体液(如血浆)中探测人类蛋白质组对于生物标志物和药物靶点的发现很有吸引力。最近,基于多重抗体的蛋白质组学技术取得了突破,现在可以以低至亚 fg/ml 的浓度同时定量数千种蛋白质,动态范围高达 10 个对数。本文提供了一个全面的指南,介绍了用于蛋白质多重超灵敏测量的现有和新兴技术的方法学、性能、技术比较、优点和缺点。全面了解这些创新对于选择适合手头应用的正确的多重蛋白质组学工具至关重要,这可以使研究人员比以往任何时候都更接近阐明疾病机制中跨越多种蛋白质的复杂相互作用和交流。